Key result
Alcohol septal ablation successfully reduced the resting left ventricular outflow tract gradient from 150 mm Hg to 13 mm Hg and improved mitral regurgitation from severe to mild.
Why the study?
Does alcohol septal ablation improve LVOT obstruction and MR in patients with hypertrophic cardiomyopathy?
Case Report (n=1)
Does alcohol septal ablation improve LVOT obstruction and MR in patients with hypertrophic cardiomyopathy?
Alcohol septal ablation is a viable treatment for severe LVOT obstruction and mitral regurgitation in hypertrophic cardiomyopathy.
May support alcohol septal ablation for severe LVOT obstruction; leaves open confirmation in larger trials.
• Hypertrophic cardiomyopathy is a common genetic heart disease. • Patients can have variable clinical manifestations and severity of disease. • Manifestations include LVOT obstruction and MR. • Alcohol septal ablation can successfully treat LVOT obstruction and MR. [Figure: see text]
No takes yet. Share an insight, caveat, or question.
Morcos et al. (2022) conducted a case report in Hypertrophic cardiomyopathy with severe LVOT obstruction and mitral regurgitation (n=1). Alcohol septal ablation was evaluated on Reduction in LVOT gradient and mitral regurgitation severity. Alcohol septal ablation successfully reduced the resting left ventricular outflow tract gradient from 150 mm Hg to 13 mm Hg and improved mitral regurgitation from severe to mild.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: